Eligible Debilitating Medical Conditions
Is the list of “debilitating medical conditions” limited? YES – As defined in section 121 of HRS-329 , a qualifying debilitating medical condition includes:
- Amyotrophic Lateral Sclerosis (added effective December 19, 2017 as per the petition process)
- Lupus (added effective June 29, 2017 as per Act 041, SHL 2017)
- Epilepsy (added effective June 29, 2017 as per Act 041, SHL 2017)
- Multiple Sclerosis (added effective June 29, 2017 as per Act 041, SHL 2017)
- Rheumatoid Arthritis (added effective June 29, 2017 as per Act 041, SHL 2017)
- Positive status for human immunodeficiency virus,
- Acquired immune deficiency syndrome,
- Post-traumatic stress disorder (added effective July 1, 2015 as per Act 241, SLH 2015), or
- “The treatment of these conditions”, or
- “A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:
- Cachexia or wasting syndrome,
- Severe pain,
- Severe nausea,
- Seizures, including those characteristic of epilepsy, or
- Severe and persistent muscle spasms, including those characteristic of multiple sclerosis or Crohn’s disease.
Has the list of debilitating medical conditions ever changed since the program began in 2000? YES – Act 241, SHL 2015 – Hawaii’s Dispensary Legislation, added post-traumatic stress disorder (PTSD) as a new condition effective July 1, 2015 and Act 041, SHL 2017 added lupus, epilepsy, multiple sclerosis, and rheumatoid arthritis effective June 29, 2017.
Is there a way to add a debilitating medical condition that is not currently stated in the law? YES – In the DOH Administrative Rules, Chapter 11-160, HAR, a process for department approved conditions has been outlined. See Petition Process for more information.